The Pharmaletter

One To Watch

onko_innate_company

oNKo-innate

"oNKo-innate is a discovery-stage biotechnology company dedicated to target identification and pre-clinical immuno-oncology drug development."

"With our deep understanding of NK cells, we aim to be the first to truly therapeutically harness the cancer-fighting abilities of these remarkable white blood cells. For more information on oNKo-innate, visit www.onko-innate.com."

Want to Update your Company's Profile?


Latest oNKo-innate News

More oNKo-innate news >